Comparison of Clinical Performance and Hemocompatibility of Dialyzers Applied During Post-dilution Online Hemodiafiltration

NACompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

May 5, 2023

Study Completion Date

May 5, 2023

Conditions
Renal FailureEnd Stage Renal Disease
Interventions
DEVICE

Dialyser

Three consecutive treatment periods of four weeks, one last study week where the patient is re-assigned to the same type of dialyzer used before beginning the study and one follow-up week per patient. Each treatment period includes 12 hemodiafiltration HDF sessions and is assigned to one type of dialyzer: FX CorAL 600 Fresenius Medical Care, comparator FX CorDiax 600 Fresenius Medical Care and comparator xevonta Hi 15 (B. Braun).

Trial Locations (8)

1077

Péterfy II. Dialízis Központ, Budapest

2600

Váci Dialízis Központ, Vác

24106

PHV Dialysezentrum Kiel, Kiel

24939

Diakonissenkrankenhaus Flensburg, Flensburg

30625

Zentrum für Nieren-, Hochdruck- und Stoffwechselerkrankungen, Hanover

38642

PHV-Dialysezentrum Goslar, Goslar

288 02

Fresenius Nephrocare Nymburk, Nymburk

190 61

Fresenius Nephrocare Praha 9 - Vysocany, Prague

All Listed Sponsors
collaborator

Institut Dr. Schauerte GmbH (IDS)

UNKNOWN

lead

Fresenius Medical Care Deutschland GmbH

INDUSTRY

NCT04714281 - Comparison of Clinical Performance and Hemocompatibility of Dialyzers Applied During Post-dilution Online Hemodiafiltration | Biotech Hunter | Biotech Hunter